Registration Dossier

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1995
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1995
Report date:
1995

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
fixed dose procedure
Limit test:
yes

Test material

Constituent 1
Details on test material:
- Name of test material (as cited in study report): MADQUAT MC 75
- Physical state: liquid
- Analytical purity: 75.5%
- Impurities (identity and concentrations): not specified
- Composition of test material, percentage of components: 100%
- Purity test date: not specified
- Lot/batch No.: M 67 bis
- Expiration date of the lot/batch: December 1995
- Stability under test conditions: stable
- Storage condition of test material: in the dark at room temperature

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Iffa Credo (69210 L'Arbresle, France)
- Age at study initiation: : 8 weeks
- Weight at study initiation: 267 ± 12 g (males) and 219 ± 4 g (females)
- Fasting period before study:
- Housing: During acclimatisation: 4-7 by sex per cage, during observation: singly
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21±2°C
- Humidity (%): 30-70
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 12.1.1995 To: 26.01.1995

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: back and flank
- % coverage: approximately 10%
- Type of wrap if used: adhesive hypoallergenic aerated semi-occlusive dressing and a restraining bandage
REMOVAL OF TEST SUBSTANCE: no
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): Total volume applied: according to the body weight determined on the day of treatment and test substance specific gravity (1.104)

Duration of exposure:
24 hours
Doses:
2000 mg/kg
No. of animals per sex per dose:
10
Control animals:
not required
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Clinical signs, examined at least once a day
- Mortality: recorded at least twice a day
- Body weight: measured just before administration then on days 8 and 15.
- Necropsy of survivors performed: yes .
- macroscopic examination of the main organs: digestive tract, heart, kidneys, liver, lungs, pancreas, spleen and any other organs with obvious
abnormalities.
- microscopic examination: no

Statistics:
none

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD0
Effect level:
2 000 mg/kg bw
Based on:
test mat.
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No deaths occurred during the observation period
Clinical signs:
other: No clinical signs and cutaneous reactions were observed during the study.
Gross pathology:
Macroscopic examination of the main organs of the animals killed at the end of the study revealed no apparent abnormalities.

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Under the conditions of the test, the dermal LD50 of MADQUAT MC 75 in the rat is greater than 2000 mg/kg.